GI
EW icon

GLG Inc’s Edwards Lifesciences EW Stock Holding History

GLG Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$735K Hold
67,098
– – 0.02% 562
2013
Q3 		$779K Hold
67,098
– – 0.02% 606
2013
Q2 		$751K Buy
+67,098
New +$794K 0.02% 505

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLG Inc's EW Position: Q4 2013 in Review

GLG Inc held its Edwards Lifesciences (EW) position steady in Q4 2013 at 67,098 shares worth $735K. The position accounts for 0.02% of the portfolio, ranked #562.

GLG Inc first reported a position in EW in Q2 2013 and has held it in 3 quarters since. The position peaked at $779K in Q3 2013. 407 funds tracked by Wall St. Rank hold EW as of Q4 2013.

  • GLG Inc held 67,098 shares of Edwards Lifesciences worth $735K as of Q4 2013.
  • GLG Inc left its Edwards Lifesciences share count unchanged in Q4 2013.
  • Edwards Lifesciences made up 0.02% of GLG Inc's portfolio in Q4 2013, its #562 holding.
  • GLG Inc first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 3 quarters since.
  • GLG Inc's Edwards Lifesciences position peaked at $779K in Q3 2013.
  • 407 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.